These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Borrelia miyamotoi infection in nature and in humans. Krause PJ; Fish D; Narasimhan S; Barbour AG Clin Microbiol Infect; 2015 Jul; 21(7):631-9. PubMed ID: 25700888 [TBL] [Abstract][Full Text] [Related]
5. Assessment of Borrelia miyamotoi in febrile patients and ticks in Alsace, an endemic area for Lyme borreliosis in France. Boyer PH; Koetsveld J; Zilliox L; Sprong H; Talagrand-Reboul É; Hansmann Y; de Martino SJ; Boulanger N; Hovius JW; Jaulhac B Parasit Vectors; 2020 Apr; 13(1):199. PubMed ID: 32303256 [TBL] [Abstract][Full Text] [Related]
6. Borrelia miyamotoi Disease in an Immunocompetent Patient, Western Europe. Hoornstra D; Koetsveld J; Sprong H; Platonov AE; Hovius JW Emerg Infect Dis; 2018 Sep; 24(9):1770-1772. PubMed ID: 30124426 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a serological test for the diagnosis of Borrelia miyamotoi disease in Europe. Jahfari S; Sarksyan DS; Kolyasnikova NM; Hovius JW; Sprong H; Platonov AE J Microbiol Methods; 2017 May; 136():11-16. PubMed ID: 28259789 [TBL] [Abstract][Full Text] [Related]
9. Presence of Borrelia miyamotoi infection in a highly endemic area of Lyme disease. Marcos LA; Smith K; Reardon K; Weinbaum F; Spitzer ED Ann Clin Microbiol Antimicrob; 2020 May; 19(1):22. PubMed ID: 32473652 [TBL] [Abstract][Full Text] [Related]
10. Seroreactivity to the C6 Peptide in Borrelia miyamotoi Infections Occurring in the Northeastern United States. Molloy PJ; Weeks KE; Todd B; Wormser GP Clin Infect Dis; 2018 Apr; 66(9):1407-1410. PubMed ID: 29149281 [TBL] [Abstract][Full Text] [Related]